These data suggest that CRIPTO, as the carcinoembryonic antigen (CEA) (another GPI anchored protein and a widely used tumor marker), is able to reach the bloodstream, being potentially released by tumor cells through GPI anchor cleavage. The gene discussed is CRIPTO; the disease is neoplasm.